Impedance Vector Switching for Heart Failure Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical devices struggle to accurately detect heart failure decompensation events, particularly during the acute phase after device implantation, due to device site maturation affecting impedance signals, leading to potential false positives and delayed detection.
Innovation Solution
An ambulatory medical device with an electrical impedance analyzer circuit measuring first and second impedance vectors, an impedance vector selector circuit, and an impedance indicator generator circuit, which adjusts impedance vector selection based on device site maturation status to improve detection accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a single impedance vector is used for HF decompensation detection, then the detection method is simple, but the sensitivity and specificity are reduced during device site maturation
Solution Approach 1:
The system dynamically switches between different impedance vector configurations based on the detected device site maturation status. During acute maturation phase, the system uses a first impedance vector configuration that is less sensitive to maturation changes, while transitioning to a second impedance vector configuration after maturation stabilizes, thereby optimizing detection accuracy across different temporal phases without requiring complex manual intervention
Solution Approach 2:
The system changes the electrical impedance measurement parameters (vector configuration, electrode combinations, frequency) based on the device site maturation status. By adjusting which electrodes are used and how impedance is calculated, the system adapts to the changing tissue environment during maturation, maintaining high detection precision without increasing operational complexity
2Reliability
If impedance vectors sensitive to device site maturation are used, then detection sensitivity improves during stable phase, but false positives increase during acute phase
Solution Approach 1:
The detection process is segmented into distinct temporal phases (acute maturation phase and stable phase) with different impedance vector strategies for each phase. This segmentation allows the system to apply phase-appropriate detection algorithms, reducing false positives during acute phase while maintaining high sensitivity during stable phase
Solution Approach 2:
The system introduces an intermediary assessment of device site maturation status that mediates between the raw impedance signals and the final HF decompensation detection. This intermediary maturation assessment allows the system to distinguish between impedance changes caused by maturation versus those caused by actual heart failure events, thereby reducing false positives
3Loss of time
If device site maturation is ignored, then detection can begin immediately after implantation, but measurement precision deteriorates due to maturation effects
Solution Approach 1:
The system performs preliminary assessment and adaptation to device site maturation status before initiating reliable HF decompensation detection. By characterizing the maturation process upfront and adapting the detection algorithm accordingly, the system enables early detection capability while maintaining measurement precision throughout the maturation period
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the sensitivity and specificity of heart failure decompensation event detection by minimizing false positives and enabling timely intervention, even during the acute phase after device implantation.
Implementation Method 1
fluid accumulation in the lungs decreases the transthoracic impedance due to the lower resistivity of the fluid than air in the lungs
Data Source
AI summary
Devices and methods for detecting physiological target event such as events indicative of heart failure (HF) decompensation status are described. An ambulatory medical device (AMD) can detect device site maturation such as in a device encapsulation pocket, and classify the maturation status into one of two or more device site maturation states. The AMD can include an electrical impedance analyzer circuit that can measure a first maturation-insensitive impedance vector and a second maturation-sensitive impedance vector. At least one impedance vector can be selected or a composite impedance vector can be generated in accordance with the classified device site maturation state. The AMD can generate an impedance indicator using the selected or composite impedance vector, and detect a target physiologic event indicative of worsening of HF using the impedance indicator.